Author： Ameyar-Zazoua Maya Guasconi Valentina Ait-Si-Ali Slimane
Publisher： Informa Healthcare
ISSN： 1471-2598
Source： Expert Opinion on Biological Therapy, Vol.5, Iss.2, 2005-02, pp. : 221-224
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The RNA interference (RNAi) gene-silencing mechanism is induced by do-uble-stranded RNA (dsRNA) and is highly sequence-specific. It is an extremely powerful tool for silencing gene expression invitro, and might be used as therapy in human pathologies such as cancer, viral infections and genetic disorders. RNAi was initially discovered in plants, but it has become clear that it is also conserved in animal species. Triggering of RNAi by the introduction of small dsRNA (or small interfering RNA) into living cells as a tool to inhibit the expression of specific genes holds the promise to selectively extinguish the expression of disease-associated genes in humans. On the other hand, RNAi technology will serve to elucidate the functions and interactions of the thousands of human genes in high-throughput systems and help in target validation technology.
Related content
Access to resources
Recommend
By Liu Kun Chen Honglin You Qingsheng Shi Hai Wang Zhiwei
Molecular and Cellular Biochemistry, Vol. 386, Iss. 1-2, 2014-01 ,pp. :
By Wang Leiming Feng Jian Da Liang Li Ying Li Zaiping Zhao Mujun
Acta Biochimica et Biophysica Sinica, Vol. 45, Iss. 3, 2013-03 ,pp. :
Potential applications of siRNA for pain therapy
Expert Opinion on Biological Therapy, Vol. 4, Iss. 4, 2004-04 ,pp. :